Aim high study nejm cme

Niacin in Patients with Low HDL Cholesterol ... - nejm.org

★ ★ ★ ★ ☆

Trial Oversight. The AIM-HIGH Study was an investigator-initiated trial that was approved and sponsored by the National Heart, Lung, and Blood Institute (NHLBI).

Niacin in Patients with Low HDL Cholesterol ... - nejm.org

Safety Profile of Extended-Release Niacin in the AIM-HIGH ...

★ ★ ☆ ☆ ☆

The results of the Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides: Impact on Global Health Outcomes (AIM-HIGH) trial were published in the Journal in …

Safety Profile of Extended-Release Niacin in the AIM-HIGH ...

NEJM Knowledge+

★ ★ ☆ ☆ ☆

NEJM Knowledge+ combines gold-standard content with the most efficient, engaging and effective way to help you learn and prepare for your Board Exams.

NEJM Knowledge+

CME/MOC | Annals of Internal Medicine | American College ...

★ ★ ★ ★ ☆

Annals of Internal Medicine is a convenient way to fulfill both your CME and MOC requirements. After logging in, it takes just a few minutes to earn credit using one of two models: complete the short quiz that accompanies articles with the "CME" label or document how an article you read with the "Eligible for CME Point-of-Care" label impacted your practice.

CME/MOC | Annals of Internal Medicine | American College ...

Slide in Commercially Funded CME for Physicians - NEJM ...

★ ★ ★ ★ ★

The total number of CME providers has also declined sharply over the same time period – by some 500+ providers or 26% in total – with medical education communication companies (MECCs) taking the biggest hit as CME grant monies have migrated to medical professional societies and schools of medicine.

Slide in Commercially Funded CME for Physicians - NEJM ...

Cardiology News & Opinion – theheart.org | Medscape

★ ★ ★ ★ ★

Cardiology : Welcome to theheart.org | Medscape Cardiology, where you can peruse the latest medical news, commentary from clinician experts, major conference coverage, full-text journal articles ...

Cardiology News & Opinion – theheart.org | Medscape

AIM-HIGH Archives - CardioExchange CardioExchange

★ ★ ★ ★ ★

CME; Special Features. Clinical Spotlight ; RSS. ... William E. Boden, lead investigator of the AIM-HIGH trial, and CardioExchange’s Harlan M. Krumholz debate the current state of research on niacin therapy. ... The largest-ever study of niacin has failed to show a clinical benefit of niacin and even found a strong signal of harm. Merck ...

AIM-HIGH Archives - CardioExchange CardioExchange

After AIM HIGH, What Future for Niacin? A CardioExchange ...

★ ★ ★ ☆ ☆

11/22/2011 · With the publication and presentation of negative data from the AIM HIGH trial (see our news summary), CardioExchange convened a panel to answer this question:. What if any role remains for niacin after AIM HIGH? Steven E. Nissen, MD. The AIM HIGH Study provides no evidence for benefit from niacin in the very patients in whom this drug is most commonly used.

After AIM HIGH, What Future for Niacin? A CardioExchange ...

ACP Journal Club | Annals of Internal Medicine | American ...

★ ★ ☆ ☆ ☆

3/19/2019 · ACP Journal Club summarizes the best new evidence for internal medicine from over 120 clinical journals. Once a bimonthly stand-alone journal, ACP Journal Club is now a monthly feature of Annals of Internal Medicine.

ACP Journal Club | Annals of Internal Medicine | American ...

New CAR-T therapy data from ELIANA trial published., 02 ...

★ ★ ★ ★ ☆

Novartis announced updated results from the pivotal ELIANA clinical trial of Kymriah (tisagenlecleucel), formerly CTL019, in relapsed or refractory (r/r) pediatric and young adult patients with B-cell acute lymphoblastic leukemia (ALL) have been published in The New England Journal of Medicine (NEJM).

New CAR-T therapy data from ELIANA trial published., 02 ...

Niaspan Didn’t Work—The AIM-HIGH Study | Tom Wade MD

★ ★ ★ ★ ☆

11/22/2011 · These results are reported in the AIM-HIGH study in the November 15, 20ll New England Journal of Medicine available at ... The AIM-HIGH study shows once again that just because we think a medicine or treatment should help, that does not mean it actually does helps patients. To know if a medicine really helps patients, we need proof.

Niaspan Didn’t Work—The AIM-HIGH Study | Tom Wade MD

Niacin Is Ineffective in Patients with Established ...

★ ★ ★ ★ ☆

11/15/2011 · However, the clinical effect of this practice is unclear. In the NIH-sponsored AIM-HIGH study, 3414 patients with established cardiovascular disease were randomized to receive simvastatin plus either extended-release niacin or placebo.

Niacin Is Ineffective in Patients with Established ...

NEJM Journal Watch: Summaries of and commentary on ...

★ ★ ★ ☆ ☆

3/13/2019 · Medical News Prenatal Steroids Cost-Effective for Women at Risk for Late-Preterm Delivery Free. By Amy Orciari Herman . For women at risk for late-preterm delivery, steroid injection is a cost-effective strategy to help prevent neonatal complications, according to a secondary analysis of a randomized trial in JAMA Pediatrics.

NEJM Journal Watch: Summaries of and commentary on ...

Practice Board Question - UCSF CME

★ ★ ★ ☆ ☆

3/26/2013 2 Practice Board Question 1. What is the most common cause of death among men in the US? A. Breast cancer B. Lung cancer C. Cardiovascular disease D. Gynecological cancers E. Influenza + pneumonia Practice Board Question 1. What is the most common cause of

Practice Board Question - UCSF CME

NEJM : Studies take aim at easing CT lung screening follow-up

★ ★ ★ ★ ★

NEJM: Studies take aim at easing CT lung screening follow-up. ... In one study, an analysis of National Lung Screening Trial ... And it's a high-stakes game. More than one in five participants in low-dose CT lung cancer screening programs are found to have at least one nodule, and more than one in four patients with detected nodules who undergo ...

NEJM : Studies take aim at easing CT lung screening follow-up

Antibiotic Prophylaxis and Incidence of Endocarditis ...

★ ★ ☆ ☆ ☆

11/5/2018 · Background The American Heart Association updated its recommendations for antibiotic prophylaxis (AP) to prevent infective endocarditis (IE) in 2007, advising that AP cease for those at moderate risk of IE, but continue for those at high risk. Objectives The authors sought to quantify any change in AP prescribing and IE incidence. Methods High-risk, moderate-risk, and unknown/low-risk ...

Antibiotic Prophylaxis and Incidence of Endocarditis ...

Dietary patterns and the risk of major adverse ...

★ ★ ☆ ☆ ☆

Howard Weintraub discusses the recent NEJM study showing no benefit with fish oil in patients at high risk for CVD, and points to future trials that may change things around.

Dietary patterns and the risk of major adverse ...

CVD Benefits in Fish Oil: Is EPA the Pearl? - Medscape

★ ★ ★ ☆ ☆

9/27/2018 · Our new vision and mission statements also emphasize our aim to drive change in the learning environment, support the continuing medical education (CME) community, and simplify and align regulatory systems. ACCME's vision is a world where our community of educators supports clinicians in delivering optimal healthcare for all.

CVD Benefits in Fish Oil: Is EPA the Pearl? - Medscape

ACCME Vision and Mission; NC Joins State Medical Board ...

★ ★ ★ ★ ★

ORLANDO -- Niacin boosts high-density lipoprotein (HDL) cholesterol without benefit for clinical outcomes in otherwise well-treated patients, according to a results of a halted, and perhaps inconclusi

ACCME Vision and Mission; NC Joins State Medical Board ...

AHA: Niacin 'AIM's-HIGH but Falls Flat | Medpage Today

★ ★ ★ ★ ★

The Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin (SATURN) is a prospective, randomized, multicenter, SATURN and AIM-HIGH: ‘Back down to ...

AHA: Niacin 'AIM's-HIGH but Falls Flat | Medpage Today

SATURN and AIM-HIGH: ‘Back down to planet Earth’

★ ★ ☆ ☆ ☆

3/1/2019 · CCJM delivers practical clinical articles relevant to internists, cardiologists, endocrinologists, and other specialists, all written by known experts.

SATURN and AIM-HIGH: ‘Back down to planet Earth’

Cleveland Clinic Journal of Medicine | Cleveland Clinic ...

★ ★ ★ ★ ★

High-dose, extended-release niacin does not reduce the risk of heart attack, stroke and other cardiovascular events in patients with bad cholesterol (LDL) that is well controlled by statins. William E. Boden, MD, professor of medicine and co-principal investigator on the AIM-HIGH clinical trial ...

Cleveland Clinic Journal of Medicine | Cleveland Clinic ...

Niacin Does Not Benefit Heart Disease Patients with Low ...

★ ★ ☆ ☆ ☆

NEJM Catalyst - practical innovations in health care delivery. Ideas, solutions and cases to improve patient care and drive value in your organization.

Niacin Does Not Benefit Heart Disease Patients with Low ...

NEJM Catalyst - Home - Practical Innovations in Health ...

★ ★ ★ ★ ☆

The Cohort Study for The Treatment of Discogenic Back Pain (DISCO) Description: Discogenic back pain is a controversial diagnosis that often leads to aggressive surgical treatment. This study uses a prospective cohort design to better define the outcomes of spinal fusion for presumed discogenic pain and to compare them with outcomes of patients who have...

NEJM Catalyst - Home - Practical Innovations in Health ...

Cohort Study - Home | Department of Radiology

★ ★ ★ ★ ★

5/2/2018 · Novant Health is helping physicians find meaning and thrive again through a novel leadership development program for physician resiliency and wellness that builds self-awareness, teaches coping skills, and increases their engagement, resulting in greater fulfillment in …

Cohort Study - Home | Department of Radiology

Leadership Development Program for Physician Resiliency ...

★ ★ ★ ★ ★

High, Moderate, and Low-intensity Statin Therapy Used in Clinical Trials High-Intensity ... NEJM 2014NNEEJJMM 22001144NEJM 2014 ... ACCORD Lipids Study The ACCORD Group. N Engl J Med 2010; 362:1563-1574. 2/21/2017 5 Fibrates Reduce CHD Risk only in Patients with HTG and Low HDL-C

Leadership Development Program for Physician Resiliency ...

Fri Fazio 415 - cme.baptisthealth.net

★ ★ ★ ☆ ☆

cohort study. Evidence justifying use of high dose IV steroids is limited. Niewoehner et al’s 1999 VA trial of 271 inpatients receiving 125mg Solumedrol bolus q6hr for 72 hr followed by 60mg oral Prednisone daily for 2-8 wks. NEJM. 1999;340(25):1941-47 Table 5. Association Between Low-Dose Oral Steroid Therapy vs High-Dose Intravenous

Fri Fazio 415 - cme.baptisthealth.net

Updates in Hospitalist Medicine - spokanesocietyim.org

★ ★ ★ ★ ☆

2 Perioperative Cardiovascular Events- High Morbidity • 30+ million noncardiac surgical cases/year • 30%- CAD or risk factors • 1 million- cardiovascular complications • Perioperative MI 30 - 50% mortality

Updates in Hospitalist Medicine - spokanesocietyim.org

Pre-operative visit Surgical Patient Continued… April 13, 2012

★ ★ ★ ★ ☆

American Academy of Family Physicians (AAFP) represent more than 131,400 family physicians, family medicine residents, and medical students, providing outstanding advocacy, practice enhancement ...

Pre-operative visit Surgical Patient Continued… April 13, 2012
Antony-and-cleopatra-study-notes.html,Ap-calculus-ab-study-sheet.html,Ap-comp-sci-study-guide.html,Ap-gridworld-case-study.html,Ap-lit-exam-study-guide.html